» Articles » PMID: 11020662

Sensitive and Nonenzymatic Measurement of Hydrogen Peroxide in Biological Systems

Overview
Date 2000 Oct 6
PMID 11020662
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The increasing demand in detecting H(2)O(2) under various experimental conditions is only partly fulfilled by most conventional peroxidase-based assays. This article describes a sensitive and nonenzymatic H(2)O(2) assay that is based on the chemiluminescence reaction of luminol with hypochlorite. It allows the determination of H(2)O(2) down to nanomolar concentrations. Actual H(2)O(2) concentrations rather than a turnover of H(2)O(2) can be determined in monolayer cultures, perfusates, suspensions of intact cells, organelles, and crude homogenates. One of the strengths of this assay is that it may be used to assess fast enzyme kinetics (catalase, glutathione peroxidase, oxidases) at very low H(2)O(2) concentrations. Its use together with a glucose oxidase/catalase system appears to be a powerful tool in studying signal functions of H(2)O(2) in various biological systems on a quantitative basis. Several applications are discussed in detail to demonstrate the technical requirements and analytical potentials.

Citing Articles

Hyaluronic acid-modified redox-sensitive hybrid nanocomplex loading with siRNA for non-small-cell lung carcinoma therapy.

Chen D, Zhang P, Li M, Li C, Lu X, Sun Y Drug Deliv. 2022; 29(1):574-587.

PMID: 35156491 PMC: 8856077. DOI: 10.1080/10717544.2022.2032874.


Hydrogen Peroxide Inducible JAK3 Covalent Inhibitor: Prodrug for the Treatment of RA with Enhanced Safety Profile.

Bao Q, Zhang L, Wang N, Gabet B, Yang W, Gao X ACS Med Chem Lett. 2020; 11(11):2182-2189.

PMID: 33214827 PMC: 7667863. DOI: 10.1021/acsmedchemlett.0c00323.


Prodrug strategies for targeted therapy triggered by reactive oxygen species.

Peiro Cadahia J, Previtali V, Troelsen N, Clausen M Medchemcomm. 2019; 10(9):1531-1549.

PMID: 31673314 PMC: 6786010. DOI: 10.1039/c9md00169g.


The peroxidase PRDX1 inhibits the activated phenotype in mammary fibroblasts through regulating c-Jun N-terminal kinases.

Jezierska-Drutel A, Attaran S, Hopkins B, Skoko J, Rosenzweig S, Neumann C BMC Cancer. 2019; 19(1):812.

PMID: 31419957 PMC: 6697950. DOI: 10.1186/s12885-019-6031-4.


Signals Getting Crossed in the Entanglement of Redox and Phosphorylation Pathways: Phosphorylation of Peroxiredoxin Proteins Sparks Cell Signaling.

Skoko J, Attaran S, Neumann C Antioxidants (Basel). 2019; 8(2).

PMID: 30678096 PMC: 6406269. DOI: 10.3390/antiox8020029.